Back to School: How biopharma can reboot drug development. Access exclusive analysis here
OSI (NASDAQ:OSIP) raised $175 million in a bumped-up placement of convertible senior subordinated
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury